Kiwis with advanced triple negative breast cancer get the news they’ve been waiting for

Kiwis with advanced triple negative breast cancer get the news they’ve been waiting for

It’s a historic day for New Zealanders with the most aggressive form of breast cancer, as Pharmac announces a consultation that would see pembrolizumab (brand name Keytruda) funded for people with advanced triple negative breast cancer (TNBC) from 1 October.

Keytruda will be the first…

[ad_2]

Source link

More From Author

Scientists discover new T cells and genes related to immune disorders

Scientists discover new T cells and genes related to immune disorders

Bath reports first rabies case in more than 4 years

Bath reports first rabies case in more than 4 years

Leave a Reply

Your email address will not be published. Required fields are marked *